Recurrent Adult Acute Myeloid Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2022-03-31
Mar 31, 2022
C
Terminated
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +8 more
  • Duarte, California
    City of Hope Medical Center
2022-03-28
Mar 28, 2022
C
Terminated
  • Adult Acute Myeloid Leukemia in Remission
  • +14 more
  • Duarte, California
    City of Hope
2022-03-28
Mar 28, 2022
S
Completed
  • Minimal Residual Disease
  • +3 more
  • Daratumumab
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2022-03-02
Mar 2, 2022
M
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +25 more
  • Allogeneic Natural Killer Cell Line NK-92
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-01
Mar 1, 2022
C
Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
2022-02-28
Feb 28, 2022
C
Active, not recruiting
  • Adult Acute Myeloid Leukemia in Remission
  • +12 more
  • Duarte, California
    City of Hope Medical Center
2022-02-17
Feb 17, 2022
C
Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Complete Remission
  • +7 more
  • Bone Marrow Transplantation
  • +7 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
2022-02-17
Feb 17, 2022
O
Recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +14 more
  • radiation therapy
  • +8 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
2022-01-29
Jan 29, 2022
M
Recruiting
  • Myelodysplastic Syndrome
  • +16 more
  • Computed Tomography
  • +6 more
  • Scottsdale, Arizona
  • +2 more
2022-02-03
Feb 3, 2022
D
Active, not recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Recurrent Adult Acute Myeloid Leukemia
  • Boston, Massachusetts
  • +1 more
2022-01-25
Jan 25, 2022
N
Active, not recruiting
  • Acute Erythroid Leukemia
  • +8 more
  • Chicago, Illinois
  • +6 more
2022-01-25
Jan 25, 2022
U
Completed
  • Adult Acute Myeloid Leukemia in Remission
  • Recurrent Adult Acute Myeloid Leukemia
  • Aurora, Colorado
  • +1 more
2021-12-30
Dec 30, 2021
U
Recruiting
  • Previously Treated Myelodysplastic Syndrome
  • +3 more
  • Fludarabine Phosphate
  • +9 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
2022-01-07
Jan 7, 2022
W
Active, not recruiting
  • Granulocytic Sarcoma
  • Recurrent Adult Acute Myeloid Leukemia
  • 6,8-Bis(benzylthio)octanoic Acid
  • +3 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
2022-01-03
Jan 3, 2022
W
Recruiting
  • Recurrent Adult Acute Myeloid Leukemia
  • Untreated Adult Acute Myeloid Leukemia
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
2021-12-21
Dec 21, 2021
N
Active, not recruiting
  • Acute Myeloid Leukemia
  • +19 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Lewes, Delaware
  • +16 more
2021-12-14
Dec 14, 2021
F
Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +17 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-13
Dec 13, 2021
N
Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Chicago, Illinois
  • +2 more
2021-11-30
Nov 30, 2021
U
Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +10 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
2021-11-17
Nov 17, 2021
S
Active, not recruiting
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +9 more
  • Sewell, New Jersey
  • +4 more
2021-11-17
Nov 17, 2021
S
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +67 more
  • Fludarabine phosphate
  • +8 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
2021-08-31
Aug 31, 2021
R
Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • choline magnesium trisalicylate
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
2021-08-20
Aug 20, 2021
R
Terminated
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +15 more
  • fludarabine phosphate
  • +4 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
2021-08-20
Aug 20, 2021